APA aipamena

Miyanaga, A., Shimizu, K., Noro, R., Seike, M., Kitamura, K., Kosaihira, S., . . . Gemma, A. (2013). Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation. BioMed Central.

Chicago Style aipamena

Miyanaga, Akihiko, et al. Activity of EGFR-tyrosine Kinase and ALK Inhibitors for EML4–ALK-rearranged Non–small–cell Lung Cancer Harbored Coexisting EGFR Mutation. BioMed Central, 2013.

MLA aipamena

Miyanaga, Akihiko, et al. Activity of EGFR-tyrosine Kinase and ALK Inhibitors for EML4–ALK-rearranged Non–small–cell Lung Cancer Harbored Coexisting EGFR Mutation. BioMed Central, 2013.